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Scientific summary
Background
Urinary incontinence (UI) following acute stroke is common, affecting between 40% and 60% of people
in hospital. National audit data suggest incontinence is often poorly managed. In Cochrane systematic
reviews, conservative interventions (e.g. bladder training and prompted voiding) have been shown to have
some effect; however, their effectiveness has not been demonstrated with stroke patients.
Programme aim
To develop, implement and evaluate the potential clinical effectiveness and cost-effectiveness of a
systematic voiding programme, with or without supported implementation, for the management of UI
after stroke in secondary care.
Design
A two phase programme.
Phase I (development):
l evidence synthesis of combined approaches to manage UI post stroke
l case study of the introduction of a systematic voiding programme (SVP) in one stroke service.
Phase II (feasibility):
l cluster randomised controlled exploratory trial, incorporating a process and health economic evaluation.
Two dedicated patient, public and carer groups, one comprising members with aphasia, collaborated on
the design and conduct of the programme.
Phase I: evidence synthesis
Objectives
l Determine whether or not combined behavioural interventions (CBIs) improve UI in
adults (effectiveness).
l Identify the barriers and enablers to successful implementation (acceptability).
l Describe and define the potential components/mechanisms of action of the intervention (predictors).
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Methods
Data sources were searched from inception to October 2008:
l Databases of published material, including Cochrane Central Register of Controlled Trials, MEDLINE,
EMBASE, Cumulative Index to Nursing and Allied Health Literature, PsycINFO and Allied and
Complementary Medicine Database.
l Databases of unpublished trials and theses, including metaRegister of Current Controlled Trials,
National Institutes of Health RePORTER (formerly CRISP), CentreWatch, National Institute for Health
Research, Index to Theses and Dissertation Abstracts International.
l Conference proceedings for the International Continence Society (ICS) (2006–8).
Study inclusion
Effectiveness review
Randomised and quasi-randomised controlled trials (RCTs) of CBIs in adults. CBIs were defined as
interventions that include more than one behavioural technique directly targeted at improving
the management of incontinence.
Acceptability and feasibility review
Studies collecting qualitative or quantitative data from service users or staff about their perceptions of
experiences of behavioural interventions.
Predictors of adherence or treatment outcome review
Observational studies or clinical trials that included multivariate analysis on the association between a
predictor variable and treatment adherence to a behavioural UI intervention of any kind, or treatment
outcome for a CBI.
Results
Effectiveness
Ten studies with 13 intervention–comparison pairs and 1163 participants. For the primary outcome of
number of people remaining incontinent at post treatment, results for comparisons with another treatment
were marginally non-significant [relative risk (RR) 0.87, 95% confidence interval (CI) 0.75 to 1.01]. Results
for non-treatment comparisons were significant, favouring the CBI (RR 0.81, 95% CI 0.70 to 0.94).
Acceptability and feasibility
Six studies involving 184 participants identified service users’ views. Barriers to continence promotion
included increased fear of being wet, attitude to exercises and fitting them into daily life. For elderly
people in residential care, influencing factors included a tolerance for UI symptoms and a preference for
interventions that facilitated independence from staff. Enablers to participation included having realistic
goals and expectations, and gaining a sense of mastery and control.
Six studies involving 427 participants identified staff views. Barriers to continence promotion included aims
of treatment, staff motivation, education and conflicting work priorities. Enablers to the promotion of
continence included staff education, adequate staffing and experience of success.
Predictors of adherence or treatment outcome
Seven studies with 882 participants identified independent predictors using multivariate analysis. The only
variable confirmed as a predictor of improvement in more than one study was treatment adherence.
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Phase I: case study
Objectives
l Identify the organisational context for embedding a SVP.
l Explore health professionals’ views around embedding the SVP into practice.
l Measure presence/absence of UI and frequency of UI.
Design
Mixed-methods single case study including diagnostic analysis of context using interviews with clinical
leaders analysed with soft systems methodology; a process evaluation using interviews with staff delivering
the intervention and analysed with normalisation process theory (NPT); and outcome evaluation using
data collected from patients receiving the SVP and analysed using descriptive statistics.
Setting
An 18-bedded acute stroke unit in a large trust serving a population of 370,000.
Participants
Health professionals and clinical leaders with a role in either delivering the SVP or linking with it in any capacity
were recruited. Patients were aged ≥ 18 years with a diagnosis of stroke and UI as defined by the ICS.
Intervention
A SVP comprising assessment (including a comprehensive continence assessment), individualised conservative
interventions tailored to the physical and cognitive capabilities of each patient and weekly review.
Results
Organisational context
Eighteen health professionals took part in four group interviews. Findings suggest an environment not
conducive to therapeutic continence management and a focus on containment.
Embedding the systematic voiding programme into practice
Twenty-one unit staff took part in six group interviews. After initial confusion there was an embedding of
processes facilitated by new routines and procedures.
Outcome evaluation
Forty-three patients were recruited, 28 commencing the SVP. Of these, six out of 28 (21%) were continent
at 6 weeks post-stroke or discharge.
Conclusion
It was possible to embed the SVP into practice despite an organisational context not conducive to
therapeutic continence care.
Phase II: exploratory cluster randomised controlled trial with
integrated process and health economic evaluation
Objectives
l Assess feasibility in terms of rates of participant recruitment and retention.
l Assess fidelity to the intervention.
l Conduct a qualitative assessment of feasibility from the perspective of multiple stakeholders.
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l Conduct a preliminary evaluation of supported implementation (using facilitation as an implementation
strategy to support and enable people to change their practice) compared with implementation alone.
l Investigate patient-related factors affecting patient outcome.
l Investigate stroke service-level factors potentially affecting stroke service outcomes to estimate the
amount of unexplained variability in outcomes between trusts and between patients.
l Confirm the choice of primary and secondary outcome measures for a full-scale cluster randomised trial
to evaluate effectiveness.
l Develop and test data collection tools for an economic evaluation within a full-scale cluster
randomised trial.
Design
A three-arm, parallel, open, exploratory, pragmatic, cluster RCT of a SVP, with or without supported
implementation, for the management of UI after stroke in secondary care.
Setting
Twelve NHS stroke services in England and Wales.
Participants
Four hundred and thirteen patients with UI were recruited between 1 January 2011 and 31 July 2012;
124 usual care, 164 intervention and 125 supported implementation.
Baseline data were collected for all patients. The overall response rate at 6 weeks was 85% (306/362),
excluding patients recruited at 6 weeks and those who had died. At 12 weeks, the overall response rate
was 88% (330/374), excluding one patient recruited at 12 weeks and those who had died. At 52 weeks,




Primary outcome was presence/absence of incontinence measured by the International Consultation on
Incontinence Modular Questionnaire (ICIQ). Secondary outcomes were quality of life (QoL), frequency and
severity of incontinence, urinary symptoms and activities of daily living.
Results
There was no suggestion of a beneficial effect of the intervention on outcome at 6 weeks post stroke.
Findings were similar at 12 weeks post stroke [intervention vs. usual care: odds ratio (OR) 1.02,
95% CI 0.54 to 1.93; supported implementation vs. usual care: OR 1.06, 95% CI 0.54 to 2.09].
There was no evidence of better outcomes on the ICIQ or Incontinence Severity Index at 6 weeks post stroke.
At 12 weeks, there was weak evidence of better outcomes on the ICIQ in supported implementation
(OR 1.22, 95% CI 0.72 to 2.08), but the CI is wide and includes both clinically relevant benefit and harm. Both
intervention arms had higher estimated odds of continence for patients with urge incontinence than usual care
(intervention: OR 1.58, 95% CI 0.83 to 2.99; supported implementation: OR 1.73, 95% CI 0.88 to 3.43). There
was a similar increase in the estimated odds of continence for patients with stress incontinence in supported
implementation (OR 1.82, 95% CI 0.82 to 4.01), but this was not as marked in intervention (OR 1.04, 95% CI
0.45 to 1.82). Findings are suggestive of a potential reduction in the odds of specific types of incontinence.
Per-protocol analysis suggested that those who received the intervention according to protocol had better
outcomes than usual care, although this did not appear to hold for supported implementation (OR relative to
usual care intervention: 1.52, 95% CI 0.67 to 3.41; supported implementation 1.02, 95% CI 0.38 to 2.76).
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An integrated multiple component evaluation, underpinned by a logic model, was conducted in order to
describe implementation and assist in explaining why the intervention and its components were or were
not successful.
Delivery of the intervention to individuals: assessed through an analysis of adherence to the protocol in
terms of management of catheterisation and intervention documentation.
Response of individuals: assessed through semistructured interviews with patients at discharge.
Response of clusters, recruitment and reach in individuals, delivery to and response of individuals and
maintenance of processes over time: assessed using NPT. Qualitative, semistructured interviews with health
professionals involved in the intervention to explore experiences of implementation.
Context in which the trial was conducted: assessed using soft systems methodology.
Results
Delivering the intervention
Some aspects of catheterisation appeared closer to protocol recommendations in supported implementation
in terms of catheter removal [median 13 days, interquartile range (IQR) 5–35 days vs. median 20 days,
IQR 8.75–35.25] and patients still catheterised at discharge (19, 15.2% vs. 35, 21.3%).
Documentation of the regime interval and the schedule of proposed voiding times in the clinical logs was
done on less than half of occasions (38.9% in intervention; 31.9% in supported implementation).
Response of individuals
Twelve interviews with participants from six sites, eight from intervention and four from
supported implementation.
Findings categorised according to the logic model are:
l Thinking: educational element of the intervention helped participants understand that post-stroke UI
was a common and treatable problem.
l Planning: knowledge of ward systems was important, for example in timing toileting requests to allow
for delays at ‘busy’ times.
l Doing: perseverance and adaptation of the programme were identified as important.
l Evaluating: setting and achieving realistic outcomes was important.
Response of clusters
Thirty-two interviews, conducted with 38 staff from intervention sites. Findings describing embedding are:
l Thinking: taking part in Identifying Continence OptioNs after Stroke and introducing the SVP led to
changed perceptions of continence as a legitimate focus for rehabilitative practice.
l Planning: the logical structure provided by the SVP enabled a route to improved planning of care.
l Doing: the SVP helped staff make the shift to practice ‘routinised’ around 2-hourly toileting.
Individualising voiding intervals were difficult to achieve.
l Evaluating: the SVP increased the visibility of continence management through greater evaluation of
patients’ trajectories and outcomes and closer attention to workload.
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Context
Fifty interviews, conducted with 59 staff from all 12 sites. Findings describing pre-intervention context are:
l Thinking: nursing was ascribed with expertise in continence, but in reality no evidence was being used
and practice revolved around containment.
l Planning: the default position regarding services was a lack of clinical leadership and a mismatch
between skills, knowledge and practice.
l Doing: there were strong contextual barriers to individualised continence management, including
insurmountable routine systems.
l Evaluating: services within the trial demonstrated little, if any, attention to systematic evaluation of
clinical practice or patient outcomes around UI.
Health economic evaluation
Objective
The development and evaluation of data collection methods to inform an economic evaluation within a
full-scale cluster randomised trial. This included description of the costs associated with the SVP and
a preliminary exploration of potential cost-effectiveness.
Methods
Data were recorded on the cost of the training, the programme and post-hospital resources. Resource use
and trial data were combined to assess evidence of potential cost-effectiveness.
Results
The cost of the SVP had to be calculated using staff estimates. These were provided by 8 out of 12 (66.7%)
of the sites, which translated into an average per patient cost for the SVP of £1482 (intervention) and
£1830 (supported implementation). The total cost of training was £12,185 per trial arm with an additional
cost of £9642 for supporting implementation. The postal questionnaire response rate for eligible patients
was approximately 73% and 56% at 12 and 52 weeks, respectively; response rates were similar across
groups. When questionnaires were returned, the response rates across items varied but there was little
difference between groups regarding the number of items completed. The programme draws on resources
in the short term but we did not measure the opportunity cost (fewer patients being incontinent and its
associated reduction in input). The mean 52-week costs in the trial arms were £9563 (usual care), £12,423
(intervention) and £10,913 (supported implementation). All trial arms showed a reduction in quality-adjusted
life-years from baseline: –0.45 (usual care), –0.36 (intervention) and –0.41 (supported implementation).
It is unclear if this loss of quality-adjusted life-years is due to the SVP not working, the European Quality of
Life-5 Dimensions (on which the quality-adjusted life-year was based) failing to pick up a meaningful
difference, or a combination of factors.
Conclusions
The exploratory trial has demonstrated it is feasible to conduct a full cluster RCT.
Recommendations for research
The future trial will adopt this design with the following modifications.
Trial arms
l Include two trial arms only, intervention and usual care.
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Recruitment
l Obtain consent as soon as possible after admission, regardless of whether or not participants are
medically stable.
Data collection
l Use 12 weeks post consent as the main outcome point.
l Include reduction in incontinence episodes as a secondary outcome.
l Consider approaches to increasing response rate at long-term follow-up.
l Introduce more rigorous procedures for monitoring catheterisation (including ‘trial without catheter’).
Health economic component:
l Record in-hospital episodes of incontinence and the resources required to respond to such episodes.
l Identify resources required to perform the programme through direct observation.
l Consider obtaining post-hospital resource use data by asking patients to maintain diaries or going
directly to providers of services.
l Identify resource use items more directly related to the effects of incontinence.
l Include a range of QoL measures.
Study registration
This study is registered as ISRCTN08609907.
Funding
The National Institute for Health Research Programme Grants for Applied Research programme. Excess
treatment costs and research support costs were funded by participating NHS trusts and health boards,
Lancashire and Cumbria and East Anglia Comprehensive Local Research Networks and the Welsh National
Institute for Social Care and Health Research.
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